Top Markets
Coin of the day
Mosaic ImmunoEngineering Inc. Mosaic ImmunoEngineering Inc.

Mosaic ImmunoEngineering Inc.

CPMV
株式のランク #38778
Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to... Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to the advancement and commercialization of an immunomodulatory platform technology. This innovative platform aims to provide therapeutic solutions for cancer and infectious diseases in both human and animal health. The company's core product is MIE-101, a nanoparticle-based treatment sourced from the cowpea mosaic virus, which has demonstrated non-infectious characteristics in mice, dogs, and humans. Headquartered in Novato, California, the company commenced operations in 2020.
株価
$0.106
最終同期: 2026-10-01
時価総額
$767.67K
変化(1日)
73.77%
変化(1年)
-84.81%
国
US
取引 Mosaic ImmunoEngineering Inc. (CPMV)

カテゴリー

Mosaic ImmunoEngineering Inc.(CPMV)の配当利回りの履歴
Mosaic ImmunoEngineering Inc.(銘柄コード: CPMV)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Mosaic ImmunoEngineering Inc.(CPMV)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
年 配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)